Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic properties

Vascular Pharmacology

Volumn 70, Issue , 2015, Pages 1-7

  Ricci, Chiara ^a   Ferri, Nicola ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

Atherosclerosis; Natural compounds; PDGF; Smooth muscle cells

Indexed keywords

BLOCKING ANTIBODY; HETERODIMER; NATURAL PRODUCT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT; CARDIOVASCULAR AGENT; PLANT EXTRACT;

ANGIOPLASTY; ANTIATHEROSCLEROSIS ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL CYCLE PROGRESSION; DRUG ACTIVITY; EXPERIMENTAL MODEL; HUMAN; IN VITRO STUDY; INTERNAL MAMMARY ARTERY; INTRACELLULAR SIGNALING; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR REMODELING; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROTIC PLAQUE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; MEDICINAL PLANT; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYTOTHERAPY; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MOLECULAR TARGETED THERAPY; MUSCLE, SMOOTH, VASCULAR; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84930767714     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.02.002     Document Type: Review

References (97)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Raines E.W., Ferri N. Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005, 46:1081-1092.
3. Heldin C.H., Westermark B., Wasteson A. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. Biochem J 1981, 193:907-913.
4. Antoniades H.N. Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci U S A 1981, 78:7314-7317.
5. Raines E.W., Ross R. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem 1982, 257:5154-5160.
6. Seifert R.A., Hart C.E., Phillips P.E., Forstrom J.W., Ross R., Murray M.J., et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 1989, 264:8771-8778.
7. Gilbertson D.G., Duff M.E., West J.W., Kelly J.D., Sheppard P.O., Hofstrand P.D., et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 2001, 276:27406-27414.
8. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001, 3:517-521.
9. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999, 79:1283-1316.
10. Barrett T.B., Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A 1988, 85:2810-2814.
11. Majesky M.W., Benditt E.P., Schwartz S.M. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A 1988, 85:1524-1528.
12. Barrett T.B., Gajdusek C.M., Schwartz S.M., McDougall J.K., Benditt E.P. Expression of the sis gene by endothelial cells in culture and in vivo. Proc Natl Acad Sci U S A 1984, 81:6772-6774.
13. Barrett T.B., Benditt E.P. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci U S A 1987, 84:1099-1103.
14. Evanko S.P., Raines E.W., Ross R., Gold L.I., Wight T.N. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 1998, 152:533-546.
15. Uutela M., Lauren J., Bergsten E., Li X., Horelli-Kuitunen N., Eriksson U., et al. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes. Circulation 2001, 103:2242-2247.
16. Majesky M.W., Reidy M.A., Bowen-Pope D.F., Hart C.E., Wilcox J.N., Schwartz S.M. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990, 111:2149-2158.
17. Rubin K., Tingstrom A., Hansson G.K., Larsson E., Ronnstrand L., Klareskog L., et al. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet 1988, 1:1353-1356.
18. Floege J., Hudkins K.L., Davis C.L., Schwartz S.M., Alpers C.E. Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants. J Am Soc Nephrol 1998, 9:211-223.
19. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988, 82:1134-1143.
20. Ross R., Masuda J., Raines E.W., Gown A.M., Katsuda S., Sasahara M., et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990, 248:1009-1012.
21. Abe J., Deguchi J., Takuwa Y., Hara K., Ikari Y., Tamura T., et al. Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris. Heart 1998, 79:400-406.
22. Giese N.A., Marijianowski M.M., McCook O., Hancock A., Ramakrishnan V., Fretto L.J., et al. The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler Thromb Vasc Biol 1999, 19:900-909.
23. Lewis C.D., Olson N.E., Raines E.W., Reidy M.A., Jackson C.L. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets 2001, 12:352-358.
24. Hall C.S., Raines C.P., Barnett S.H., Moore R.D., Gallant J.E. Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens. AIDS 1999, 13:1207-1212.
25. Ferns G.A., Raines E.W., Sprugel K.H., Motani A.S., Reidy M.A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129-1132.
26. Lassila M., Allen T.J., Cao Z., Thallas V., Jandeleit-Dahm K.A., Candido R., et al. Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:935-942.
27. Antoniades H.N., Scher C.D., Stiles C.D. Purification of human platelet-derived growth factor. Proc Natl Acad Sci U S A 1979, 76:1809-1813.
28. Nilsson J., Ksiazek T., Heldin C.H., Thyberg J. Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Differences between cells from young and adult animals. Exp Cell Res 1983, 145:231-237.
29. Yamaguchi H., Igarashi M., Hirata A., Tsuchiya H., Susa S., Tominaga M., et al. Characterization of platelet-derived growth factor-induced p38 mitogen-activated protein kinase activation in vascular smooth muscle cells. Eur J Clin Invest 2001, 31:672-680.
30. Bornfeldt K.E., Campbell J.S., Koyama H., Argast G.M., Leslie C.C., Raines E.W., et al. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. J Clin Invest 1997, 100:875-885.
31. Walker T.R., Moore S.M., Lawson M.F., Panettieri R.A., Chilvers E.R. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. Mol Pharmacol 1998, 54:1007-1015.
32. Page K., Li J., Hershenson M.B. Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras. Am J Respir Cell Mol Biol 1999, 20:1294-1302.
33. Ferri N., Contini A., Bernini S.K., Corsini A. Role of small GTPase protein Rac1 in cardiovascular diseases: development of new selective pharmacological inhibitors. J Cardiovasc Pharmacol 2013, 62:425-435.
34. Shirai H., Autieri M., Eguchi S. Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling. Curr Opin Nephrol Hypertens 2007, 16:111-115.
35. Adams P.D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 2001, 1471:M123-M133.
36. Ekholm S.V., Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000, 12:676-684.
37. Aleem E., Kiyokawa H., Kaldis P. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol 2005, 7:831-836.
38. Stacey D.W. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003, 15:158-163.
39. Fu M., Wang C., Zhang X., Pestell R.G. Signal transduction inhibitors in cellular function. Methods Mol Biol 2004, 284:15-36.
40. Vij N., Sharma A., Thakkar M., Sinha S., Mohan R.R. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Mol Vis 2008, 14:1020-1027.
41. Harper L., Kashiwagi Y., Pusey C.D., Hendry B.M., Domin J. Platelet-derived growth factor reorganizes the actin cytoskeleton through 3-phosphoinositide-dependent and 3-phosphoinositide-independent mechanisms in human mesangial cells. Nephron Physiol 2007, 107:45-56.
42. Li W., Fan J., Chen M., Guan S., Sawcer D., Bokoch G.M., et al. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol Biol Cell 2004, 15:294-309.
43. Bokoch G.M., Vlahos C.J., Wang Y., Knaus U.G., Traynor-Kaplan A.E. Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem J 1996, 315(Pt 3):775-779.
44. Connor K.M., Subbaram S., Regan K.J., Nelson K.K., Mazurkiewicz J.E., Bartholomew P.J., et al. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 2005, 280:16916-16924.
45. Xu J., Wang F., Van Keymeulen A., Herzmark P., Straight A., Kelly K., et al. Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 2003, 114:201-214.
46. Schneider I.C., Haugh J.M. Quantitative elucidation of a distinct spatial gradient-sensing mechanism in fibroblasts. J Cell Biol 2005, 171:883-892.
47. Rotty J.D., Wu C., Bear J.E. New insights into the regulation and cellular functions of the ARP2/3 complex. Nat Rev Mol Cell Biol 2013, 14:7-12.
48. Wu C., Haynes E.M., Asokan S.B., Simon J.M., Sharpless N.E., Baldwin A.S., et al. Loss of Arp2/3 induces an NF-kappaB-dependent, nonautonomous effect on chemotactic signaling. J Cell Biol 2013, 203:907-916.
49. Asokan S.B., Johnson H.E., Rahman A., King S.J., Rotty J.D., Lebedeva I.P., et al. Mesenchymal chemotaxis requires selective inactivation of myosin II at the leading edge via a noncanonical PLCgamma/PKCalpha pathway. Dev Cell 2014, 31:747-760.
50. Yang X., Thomas D.P., Zhang X., Culver B.W., Alexander B.M., Murdoch W.J., et al. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol 2006, 26:85-90.
51. Dong L.H., Wen J.K., Miao S.B., Jia Z., Hu H.J., Sun R.H., et al. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRbeta-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia. Cell Res 2010, 20:1252-1262.
52. Liu B., Han M., Sun R.H., Wang J.J., Liu Y.P., Wen J.K. Acetylbritannilactone induces G1 arrest and apoptosis in vascular smooth muscle cells. Int J Cardiol 2011, 149:30-38.
53. Ruan J., Luo M., Wang C., Fan L., Yang S.N., Cardenas M., et al. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood 2013, 121:5192-5202.
54. Guan H., Zhu L., Fu M., Yang D., Tian S., Guo Y., et al. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury. PLoS One 2012, 7:e34957.
55. Kim H.J., Cha B.Y., Park I.S., Lim J.S., Woo J.T., Kim J.S. Dehydroglyasperin C, a component of liquorice, attenuates proliferation and migration induced by platelet-derived growth factor in human arterial smooth muscle cells. Br J Nutr 2013, 110:391-400.
56. Chen Y.N., Huang T.F., Chang C.H., Hsu C.C., Lin K.T., Wang S.W., et al. Antirestenosis effect of butein in the neointima formation progression. J Agric Food Chem 2012, 60:6832-6838.
57. Rani U.P., Kesavan R., Ganugula R., Avaneesh T., Kumar U.P., Reddy G.B., et al. Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats. J Nutr Biochem 2013, 24:1830-1839.
58. Strong P.N. Potassium channel toxins. Pharmacol Ther 1990, 46:137-162.
59. Habermann E., Reiz K.G. On the biochemistry of bee venom peptides, melittin and apamin. Biochem Z 1965, 343:192-203.
60. Son D.J., Kang J., Kim T.J., Song H.S., Sung K.J., Yun do Y., et al. Melittin, a major bioactive component of bee venom toxin, inhibits PDGF receptor beta-tyrosine phosphorylation and downstream intracellular signal transduction in rat aortic vascular smooth muscle cells. J Toxicol Environ Health A 2007, 70:1350-1355.
61. Son D.J., Ha S.J., Song H.S., Lim Y., Yun Y.P., Lee J.W., et al. Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J Pharmacol Exp Ther 2006, 317:627-634.
62. Lee W.R., Kim K.H., An H.J., Kim J.Y., Lee S.J., Han S.M., et al. Apamin inhibits hepatic fibrosis through suppression of transforming growth factor beta1-induced hepatocyte epithelial-mesenchymal transition. Biochem Biophys Res Commun 2014, 450:195-201.
63. Kim S.J., Park J.H., Kim K.H., Lee W.R., Pak S.C., Han S.M., et al. The protective effect of apamin on LPS/fat-induced atherosclerotic mice. Evid Based Complement Alternat Med 2012, 2012:305454.
64. Breuss J.M., Cejna M., Bergmeister H., Kadl A., Baumgartl G., Steurer S., et al. Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 2002, 105:633-638.
65. Ferri N., Garton K.J., Raines E.W. An NF-kappaB-dependent transcriptional program is required for collagen remodeling by human smooth muscle cells. J Biol Chem 2003, 278:19757-19764.
66. Levkau B., Garton K.J., Ferri N., Kloke K., Nofer J.R., Baba H.A., et al. xIAP induces cell-cycle arrest and activates nuclear factor-kappaB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ Res 2001, 88:282-290.
67. von Wnuck Lipinski K., Keul P., Ferri N., Lucke S., Heusch G., Fischer J.W., et al. Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen. Circ Res 2006, 98:1490-1497.
68. Kim S.J., Park J.H., Kim K.H., Lee W.R., An H.J., Min B.K., et al. Apamin inhibits THP-1-derived macrophage apoptosis via mitochondria-related apoptotic pathway. Exp Mol Pathol 2012, 93:129-134.
69. Banks B.E., Brown C., Burgess G.M., Burnstock G., Claret M., Cocks T.M., et al. Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature 1979, 282:415-417.
70. Bi D., Toyama K., Lemaitre V., Takai J., Fan F., Jenkins D.P., et al. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem 2013, 288:15843-15853.
71. Mourre C., Fournier C., Soumireu-Mourat B. Apamin, a blocker of the calcium-activated potassium channel, induces neurodegeneration of Purkinje cells exclusively. Brain Res 1997, 778:405-408.
72. Reiser G., Binmoller F.J., Strong P.N., Hamprecht B. Activation of a K+ conductance by bradykinin and by inositol-1,4,5-trisphosphate in rat glioma cells: involvement of intracellular and extracellular Ca2+. Brain Res 1990, 506:205-214.
73. Kima J., Kima K., Leea W., Ana H., Leea S., Hanb S., et al. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway. Vascul Pharmacol 2015, 70:8-14.
74. Yoo K.D., Park E.S., Lim Y., Kang S.I., Yoo S.H., Won H.H., et al. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rbeta phosphorylation. Vascul Pharmacol 2012, 56:91-97.
75. Guan H., Gao L., Zhu L., Yan L., Fu M., Chen C., et al. Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation. J Cell Biochem 2012, 113:1198-1207.
76. Lamy S., Bedard V., Labbe D., Sartelet H., Barthomeuf C., Gingras D., et al. The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation. Cancer Prev Res (Phila) 2008, 1:452-459.
77. Guo J., Li L., Wu Y.J., Yan Y., Xu X.N., Wang S.B., et al. Inhibitory effects of Brazilin on the vascular smooth muscle cell proliferation and migration induced by PDGF-BB. Am J Chin Med 2013, 41:1283-1296.
78. Cha B.Y., Shi W.L., Yonezawa T., Teruya T., Nagai K., Woo J.T. An inhibitory effect of chrysoeriol on platelet-derived growth factor (PDGF)-induced proliferation and PDGF receptor signaling in human aortic smooth muscle cells. J Pharmacol Sci 2009, 110:105-110.
79. Kim T.J., Han H.J., Hong S.S., Hwang J.H., Hwang B.Y., Yoo H.S., et al. Cudratricusxanthone A isolated from the root bark of Cudrania tricuspidata inhibits the proliferation of vascular smooth muscle cells through the suppression of PDGF-receptor beta tyrosine kinase. Biol Pharm Bull 2007, 30:805-809.
80. Zeng X., Cheng Y., Qu Y., Xu J., Han Z., Zhang T. Curcumin inhibits the proliferation of airway smooth muscle cells in vitro and in vivo. Int J Mol Med 2013, 32:629-636.
81. Liu Y., Dolence J., Ren J., Rao M., Sreejayan N. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function. J Cardiovasc Pharmacol 2008, 52:422-429.
82. Lamy S., Beaulieu E., Labbe D., Bedard V., Moghrabi A., Barrette S., et al. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 2008, 29:1033-1041.
83. Masamune A., Satoh M., Kikuta K., Suzuki N., Satoh K., Shimosegawa T. Ellagic acid blocks activation of pancreatic stellate cells. Biochem Pharmacol 2005, 70:869-878.
84. Lee M.H., Kwon B.J., Koo M.A., You K.E., Park J.C. Mitogenesis of vascular smooth muscle cell stimulated by platelet-derived growth factor-bb is inhibited by blocking of intracellular signaling by epigallocatechin-3-O-gallate. Oxid Med Cell Longev 2013, 2013:827905.
85. Kim H.J., Cha B.Y., Choi B., Lim J.S., Woo J.T., Kim J.S. Glyceollins inhibit platelet-derived growth factor-mediated human arterial smooth muscle cell proliferation and migration. Br J Nutr 2012, 107:24-35.
86. Lo H.M., Tsai Y.J., Du W.Y., Tsou C.J., Wu W.B. A naturally occurring carotenoid, lutein, reduces PDGF and H(2)O(2) signaling and compromised migration in cultured vascular smooth muscle cells. J Biomed Sci 2012, 19:18.
87. Kim J.H., Jin Y.R., Park B.S., Kim T.J., Kim S.Y., Lim Y., et al. Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation. Biochem Pharmacol 2005, 69:1715-1721.
88. Chen C.P., Hung C.F., Lee S.C., Lo H.M., Wu P.H., Wu W.B. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF. Naunyn Schmiedebergs Arch Pharmacol 2010, 381:401-414.
89. Lo H.M., Hung C.F., Tseng Y.L., Chen B.H., Jian J.S., Wu W.B. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem Pharmacol 2007, 74:54-63.
90. Akiba S., Yamaguchi H., Kumazawa S., Oka M., Sato T. Suppression of oxidized LDL-induced PDGF receptor beta activation by ginkgo biloba extract reduces MMP-1 production in coronary smooth muscle cells. J Atheroscler Thromb 2007, 14:219-225.
91. Takimoto T., Suzuki K., Arisaka H., Murata T., Ozaki H., Koyama N. Effect of N-(p-coumaroyl)serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells. Mol Nutr Food Res 2011, 55:1561-1571.
92. Kuo J.J., Wang C.Y., Lee T.F., Huang Y.T., Lin Y.L. Paeoniae radix reduces PDGF-stimulated hepatic stellate cell migration. Planta Med 2012, 78:341-348.
93. Son D.J., Kim S.Y., Han S.S., Kim C.W., Kumar S., Park B.S., et al. Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling. Biochem Biophys Res Commun 2012, 427:349-354.
94. Park E.S., Lim Y., Hong J.T., Yoo H.S., Lee C.K., Pyo M.Y., et al. Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway. Vascul Pharmacol 2010, 53:61-67.
95. Ong E.T., Hwang T.L., Huang Y.L., Lin C.F., Wu W.B. Vitisin B, a resveratrol tetramer, inhibits migration through inhibition of PDGF signaling and enhancement of cell adhesiveness in cultured vascular smooth muscle cells. Toxicol Appl Pharmacol 2011, 256:198-208.
96. Sparwel J., Vantler M., Caglayan E., Kappert K., Fries J.W., Dietrich H., et al. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation. Cardiovasc Res 2009, 81:758-770.
97. Furst R., Zirrgiebel U., Totzke F., Zahler S., Vollmar A.M., Koch E. The Crataegus extract WS 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-beta. Atherosclerosis 2010, 211:409-417.